Evidence map›Paper›PMID 30405165›Full record

ArticleScientific reports2018

A versatile method for the UVA-induced cross-linking of acetophenone- or benzophenone-functionalized DNA.

Jevgenija Jakubovska, Daiva Tauraitė, Rolandas Meškys

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Light-responsive DNA nanostructures.Nature reviews. Chemistry · 2026
    Review
  2. Extract of endophytic fungus Cepalotheca foveolata (N11) inhibits lytic bacteriophage: a study on activity, cytotoxicity, and chemical profiling.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  3. Review
  4. Spatial Proofreading Amplification ofbioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Photocrosslinkable natural polymers in tissue engineering.Frontiers in bioengineering and biotechnology · 2023
    Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jevgenija JakubovskaDepartment of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio al. 7, LT-10257, Vilnius, Lithuania. jevgenija.jakubovska@bchi.vu.lt.ORCID http://orcid.org/0000-0002-8736-9569
Daiva TauraitėDepartment of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio al. 7, LT-10257, Vilnius, Lithuania.
Rolandas MeškysDepartment of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio al. 7, LT-10257, Vilnius, Lithuania.ORCID http://orcid.org/0000-0003-3125-9827
Vilnius University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioconjugation, biosensing, bioimaging, bionanomaterials, etc., are only a few examples of application of functionalized DNA. Since base-modified nucleic acids contribute not only to a broad range of biotechnological fields but also to the understanding of various cellular processes, it is crucial to design novel modifications with unique properties. Here, we demonstrate the utilization of N

Indexed as

Ultraviolet RaysAcetophenonesBenzophenonesCross-Linking ReagentsDNADNA ProbesMolecular StructureNucleic Acid HybridizationOligonucleotidesacetophenoneAcetophenonesbenzophenoneBenzophenonesCross-Linking ReagentsDNADNA ProbesOligonucleotides

Identifiers

PMID30405165
PMCPMC6220319
OpenAlexW2899512831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.